Filing Details
- Accession Number:
- 0001140361-23-002785
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-25 21:00:46
- Reporting Period:
- 2023-01-23
- Accepted Time:
- 2023-01-25 21:00:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1746473 | Pliant Therapeutics Inc. | PLRX | Pharmaceutical Preparations (2834) | 474272481 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1822619 | Mike Ouimette | C/O Pliant Therapeutics, Inc. 260 Littlefield Avenue South San Francisco CA 94080 | General Counsel & Corp. Sec'y | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-23 | 10,000 | $11.86 | 15,947 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-01-23 | 10,000 | $24.32 | 25,947 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-23 | 20,000 | $34.19 | 5,947 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-01-23 | 10,000 | $0.00 | 10,000 | $11.86 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-01-23 | 10,000 | $0.00 | 10,000 | $24.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 77,000 | 2032-01-25 | No | 4 | M | Direct | |
| 98,240 | 2030-10-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.
- 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
- 25% of the shares subject to such option vested on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Billionaire Hedge Funds
